The FDA is attempting to tackle the high costs of prescription drugs with two new proposals, but the start of 2020 suggests the FDA’s efforts may backfire. Although a new year is usually cause for ...
The proliferation of unregulated CBD products is a striking example of troubling FDA regulation delay but far from the only one. While the U.S. Food and Drug Administration (FDA) has served an invaluable role in ...